AbCellera Biologics Inc.: operating_income
| Value | {"amount": -217103000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | AbCellera Biologics Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:26:11.740565+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/cc4d936c-9046-4bc6-9107-be6dcf6b45db
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001703057-26-000012Retrieved: 2026-08-19T17:26:11.740565+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001703057/operating-income/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/cc4d936c-9046-4bc6-9107-be6dcf6b45db
History
- no predecessors — first report